Strata Skin Sciences Price to Book Ratio 2010-2024 | SSKN
Historical price to book ratio values for Strata Skin Sciences (SSKN) over the last 10 years. The current price to book ratio for Strata Skin Sciences as of November 22, 2024 is 1.38.
Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
| Strata Skin Sciences Price/Book Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | Book Value per Share | Price to Book Ratio |
| 2024-11-21 | 3.10 | 1.38 | |
| 2024-09-30 | 2.75 | $2.24 | 1.23 |
| 2024-06-30 | 3.07 | $2.71 | 1.13 |
| 2024-03-31 | 3.78 | $2.69 | 1.41 |
| 2023-12-31 | 5.50 | $3.62 | 1.52 |
| 2023-09-30 | 5.95 | $4.64 | 1.28 |
| 2023-06-30 | 9.50 | $4.85 | 1.96 |
| 2023-03-31 | 10.59 | $5.54 | 1.91 |
| 2022-12-31 | 7.90 | $6.29 | 1.26 |
| 2022-09-30 | 8.71 | $6.28 | 1.39 |
| 2022-06-30 | 9.61 | $6.43 | 1.49 |
| 2022-03-31 | 14.70 | $6.85 | 2.15 |
| 2021-12-31 | 14.65 | $7.40 | 1.98 |
| 2021-09-30 | 18.40 | $7.62 | 2.41 |
| 2021-06-30 | 15.60 | $7.61 | 2.05 |
| 2021-03-31 | 16.70 | $7.14 | 2.34 |
| 2020-12-31 | 15.00 | $7.66 | 1.96 |
| 2020-09-30 | 13.50 | $7.68 | 1.76 |
| 2020-06-30 | 11.50 | $7.93 | 1.45 |
| 2020-03-31 | 9.50 | $8.32 | 1.14 |
| 2019-12-31 | 20.80 | $8.70 | 2.39 |
| 2019-09-30 | 21.50 | $8.77 | 2.45 |
| 2019-06-30 | 24.90 | $8.95 | 2.78 |
| 2019-03-31 | 28.50 | $9.72 | 2.93 |
| 2018-12-31 | 26.00 | $10.44 | 2.49 |
| 2018-09-30 | 35.40 | $11.15 | 3.18 |
| 2018-06-30 | 20.50 | $11.20 | 1.83 |
| 2018-03-31 | 11.70 | $45.23 | 0.26 |
| 2017-12-31 | 12.30 | $46.19 | 0.27 |
| 2017-09-30 | 17.70 | $96.52 | 0.18 |
| 2017-06-30 | 24.30 | $46.87 | 0.52 |
| 2017-03-31 | 30.25 | $57.71 | 0.52 |
| 2016-12-31 | 22.00 | $67.92 | 0.32 |
| 2016-09-30 | 26.50 | $73.96 | 0.36 |
| 2016-06-30 | 30.50 | $81.37 | 0.37 |
| 2016-03-31 | 47.25 | $71.56 | 0.66 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.013B | $0.033B |
| Strata Skin Sciences, Inc. is a medical technology company which focused on the dermatology market. Its products include the XTRAC laser(R) and VTRAC(R) excimer lamp systems for treatment of psoriasis, vitiligo and other skin conditions as well as the MelaFind (R) system used for identification and management of melanoma skin cancer. Strata Skin Sciences, Inc., formerly known as MELA Sciences, Inc., is based in Horsham, Pennsylvania. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Tempus AI (TEM) | United States | $8.263B | 0.00 |
| Inspire Medical Systems (INSP) | United States | $5.580B | 174.01 |
| Hims & Hers Health (HIMS) | United States | $5.276B | 134.17 |
| Enovis (ENOV) | United States | $2.580B | 17.49 |
| Privia Health (PRVA) | United States | $2.530B | 210.80 |
| IRhythm Technologies (IRTC) | United States | $2.313B | 0.00 |
| Azenta (AZTA) | United States | $2.227B | 111.05 |
| Omnicell (OMCL) | United States | $2.043B | 66.83 |
| Clover Health Investments (CLOV) | United States | $1.684B | 0.00 |
| 10x Genomics (TXG) | United States | $1.609B | 0.00 |
| Schrodinger (SDGR) | United States | $1.484B | 0.00 |
| Phreesia (PHR) | United States | $1.098B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.701B | 0.00 |
| Standard BioTools (LAB) | United States | $0.603B | 0.00 |
| Talkspace (TALK) | United States | $0.559B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.518B | 0.00 |
| Definitive Healthcare (DH) | United States | $0.491B | 85.00 |
| Health Catalyst (HCAT) | United States | $0.466B | 0.00 |
| Pulmonx (LUNG) | United States | $0.254B | 0.00 |
| TruBridge (TBRG) | United States | $0.239B | 69.61 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.205B | 0.00 |
| American Well (AMWL) | United States | $0.123B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.115B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.077B | 0.00 |
| HeartBeam (BEAT) | United States | $0.075B | 0.00 |
| 111 (YI) | China | $0.052B | 0.00 |
| CareCloud (CCLD) | United States | $0.046B | 0.00 |
| Outset Medical (OM) | United States | $0.040B | 0.00 |
| SHL Telemedicine (SHLT) | Israel | $0.040B | 0.00 |
| Zepp Health (ZEPP) | China | $0.038B | 0.00 |
| Movano (MOVE) | United States | $0.021B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.018B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.013B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.010B | 0.00 |
| MSP Recovery (LIFW) | United States | $0.010B | 0.00 |
| Precipio (PRPO) | United States | $0.009B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.006B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.006B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.005B | 0.00 |
| Syra Health (SYRA) | United States | $0.004B | 0.00 |
| HeartSciences (HSCS) | United States | $0.002B | 0.00 |
| Zhongchao (ZCMD) | China | $0.002B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.002B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.000B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.000B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.000B | 0.00 |